Similar articles

• Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?

  Sherrod JP, Krist A. Sherrod JP, et al. J Fam Pract. 2001 Nov;50(11):928. J Fam Pract. 2001. PMID: 11711006 Review. No abstract available.
• [Drug therapy of dyslipidemias].

  Fonda M, Cattin L, Guarnieri G. Fonda M, et al. Recenti Prog Med. 2000 Jul-Aug;91(7-8):375-8. Recenti Prog Med. 2000. PMID: 10932924 Review. Italian. No abstract available.
• Dyslipidemia and coronary heart disease: management issues from Indian perspective.

  Gambhir DS, Gambhir JK, Sudha R. Gambhir DS, et al. Indian Heart J. 2000 Sep-Oct;52(5):515-6, 617. Indian Heart J. 2000. PMID: 11256772 Review. No abstract available.
• Treatment of hyperlipidemia in women.

  Basaria S, Dobs AS. Basaria S, et al. Int J Fertil Womens Med. 2000 Jan-Feb;45(1):22-33. Int J Fertil Womens Med. 2000. PMID: 10721741 Review.
• Management of hypercholesterolaemia in the patient with diabetes.

  Packard C, Olsson AG. Packard C, et al. Int J Clin Pract Suppl. 2002 Jul;(130):27-32. Int J Clin Pract Suppl. 2002. PMID: 12296606 Review.